.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Federal Trade Commission
Deloitte
Citi
Moodys
Baxter
Argus Health
Teva
Merck
Julphar

Generated: January 23, 2018

DrugPatentWatch Database Preview

Patent Applications for chlorotrianisene

« Back to Dashboard

US Patent Applications for chlorotrianisene

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
➤ Subscribe➤ SubscribeN-CHLOROPHENYLCARBAMATE AND N-CHLOROPHENYLTHIOCARBAMATE COMPOSITIONS2000-12-22Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622012-03-05
➤ Subscribe➤ SubscribeFATTY ACID-PHARMACEUTICAL AGENT CONJUGATES2000-12-05Patented Case2003-05-21
➤ Subscribe➤ SubscribeAROMATIC SULFONE HYDROXAMIC ACID METALLOPROTEASE INHIBITOR1998-11-13Expressly Abandoned -- During Examination2002-12-27
➤ Subscribe➤ SubscribePharmaceutical composition for the treatment of hepatocellular carcinoma2001-01-24Abandoned -- Failure to Respond to an Office Action2007-11-06
➤ Subscribe➤ SubscribeParticle binding to fibers2001-04-26Expressly Abandoned -- During Examination2002-03-08
➤ Subscribe➤ Subscribe49 human secreted proteins2000-12-19Abandoned -- Failure to Respond to an Office Action2002-01-14
➤ Subscribe➤ SubscribePREPARATION AND USE OF ORTHO-SULFONAMIDO BICYCLIC HETEROARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS2000-12-11Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622015-01-19
➤ Subscribe➤ SubscribeUse of certain drugs for treating nerve root injury2001-01-17Abandoned -- Failure to Respond to an Office Action2003-05-20
➤ Subscribe➤ SubscribeUSE OF CERTAIN METALLOPROTEINASE INHIBITORS FOR TREATING NERVE DISORDERS MEDIATED BY NUCLEUS PULPSUS2001-01-17Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622015-11-16
➤ Subscribe➤ SubscribePHARMACEUTICAL COMPOSITION FOR AND METHOD OF TREATING LEUKEMIA2001-02-23Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622011-05-23
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

WIPO Patent Applications for chlorotrianisene

WIPO Patent Application Title Patent Filing Date
➤ Subscribe
➤ Subscribe
➤ Subscribe
➤ Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Moodys
Harvard Business School
Citi
UBS
Express Scripts
Fish and Richardson
Cipla
Farmers Insurance
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot